WO2002003787A3 - Souris transgéniques contenant des disruptions géniques ciblées - Google Patents

Souris transgéniques contenant des disruptions géniques ciblées Download PDF

Info

Publication number
WO2002003787A3
WO2002003787A3 PCT/US2001/021427 US0121427W WO0203787A3 WO 2002003787 A3 WO2002003787 A3 WO 2002003787A3 US 0121427 W US0121427 W US 0121427W WO 0203787 A3 WO0203787 A3 WO 0203787A3
Authority
WO
WIPO (PCT)
Prior art keywords
transgenic mice
targeted gene
mice containing
gene disruptions
gene
Prior art date
Application number
PCT/US2001/021427
Other languages
English (en)
Other versions
WO2002003787A2 (fr
Inventor
Keith D Allen
Michael W Leviten
Original Assignee
Deltagen Inc
Keith D Allen
Michael W Leviten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deltagen Inc, Keith D Allen, Michael W Leviten filed Critical Deltagen Inc
Priority to AU2001271878A priority Critical patent/AU2001271878A1/en
Publication of WO2002003787A2 publication Critical patent/WO2002003787A2/fr
Publication of WO2002003787A3 publication Critical patent/WO2002003787A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne des souris transgéniques, ainsi que des compositions et procédés se rapportant à la caractérisation d'une fonction génique. L'invention concerne plus particulièrement des souris transgéniques présentant des mutations dans un gène cible. De telles souris transgéniques, qui conviennent comme modèles pour des affections, et pour identifier des agents modulant l'expression génique et la fonction génique, conviennent également comme traitements potentiels pour diverses maladies et divers états pathologiques.
PCT/US2001/021427 2000-07-06 2001-07-06 Souris transgéniques contenant des disruptions géniques ciblées WO2002003787A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001271878A AU2001271878A1 (en) 2000-07-06 2001-07-06 Transgenic mice containing targeted gene disruptions

Applications Claiming Priority (32)

Application Number Priority Date Filing Date Title
US21610900P 2000-07-06 2000-07-06
US21625800P 2000-07-06 2000-07-06
US21676800P 2000-07-06 2000-07-06
US21625100P 2000-07-06 2000-07-06
US60/216,251 2000-07-06
US60/216,109 2000-07-06
US60/216,768 2000-07-06
US60/216,258 2000-07-06
US21744900P 2000-07-10 2000-07-10
US21745000P 2000-07-10 2000-07-10
US21766000P 2000-07-10 2000-07-10
US60/217,660 2000-07-10
US60/217,449 2000-07-10
US60/217,450 2000-07-10
US22167000P 2000-07-27 2000-07-27
US22149100P 2000-07-27 2000-07-27
US22166900P 2000-07-27 2000-07-27
US60/221,491 2000-07-27
US60/221,670 2000-07-27
US60/221,669 2000-07-27
US22346000P 2000-08-07 2000-08-07
US22317200P 2000-08-07 2000-08-07
US22317000P 2000-08-07 2000-08-07
US60/223,172 2000-08-07
US60/223,460 2000-08-07
US60/223,170 2000-08-07
US24411100P 2000-10-26 2000-10-26
US24403700P 2000-10-26 2000-10-26
US60/244,037 2000-10-26
US60/244,111 2000-10-26
US30121701P 2001-06-26 2001-06-26
US60/301,217 2001-06-26

Publications (2)

Publication Number Publication Date
WO2002003787A2 WO2002003787A2 (fr) 2002-01-17
WO2002003787A3 true WO2002003787A3 (fr) 2003-08-14

Family

ID=27585827

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/021427 WO2002003787A2 (fr) 2000-07-06 2001-07-06 Souris transgéniques contenant des disruptions géniques ciblées

Country Status (2)

Country Link
AU (1) AU2001271878A1 (fr)
WO (1) WO2002003787A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2374870A (en) * 2001-01-26 2002-10-30 Thromb X Nv Use of genetically modified multicellular animals in the identification of drug target proteins

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011238A2 (fr) * 1996-09-13 1998-03-19 Dana-Farber Cancer Institute Protease m, une nouvelle serine protease
WO1998054307A1 (fr) * 1997-05-30 1998-12-03 Schering Aktiengesellschaft Souris a gene inactive et leur descendance, a genes de serine protease dissocies
WO2000036910A1 (fr) * 1998-12-22 2000-06-29 Albert Einstein College Of Medicine Souris dont le gene msh5 a ete modifie et utilisations de ces dernieres

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011238A2 (fr) * 1996-09-13 1998-03-19 Dana-Farber Cancer Institute Protease m, une nouvelle serine protease
WO1998054307A1 (fr) * 1997-05-30 1998-12-03 Schering Aktiengesellschaft Souris a gene inactive et leur descendance, a genes de serine protease dissocies
WO2000036910A1 (fr) * 1998-12-22 2000-06-29 Albert Einstein College Of Medicine Souris dont le gene msh5 a ete modifie et utilisations de ces dernieres

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
WONG GUANG W ET AL: "Cloning of the human homolog of mouse transmembrane tryptase.", INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, vol. 118, no. 2-4, February 1999 (1999-02-01), pages 419 - 421, XP001100094, ISSN: 1018-2438 *
WONG GUANG W ET AL: "Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 43, 22 October 1999 (1999-10-22), pages 30784 - 30793, XP002213262, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2002003787A2 (fr) 2002-01-17
AU2001271878A1 (en) 2002-01-21

Similar Documents

Publication Publication Date Title
WO2002079440A8 (fr) Souris transgeniques contenant des ruptures du gene gpcr5-1
WO2002079424A3 (fr) SOURIS TRANSGENIQUES CONTENANT DES DISRUPTIONS DE GENES Gβ3GALT2
WO2002046390A3 (fr) Souris transgeniques a disruptions geniques de tyrosine phosphatase rptpb
WO2002079438A3 (fr) Disruptions du gene ogr1, compositions et procedes associes
WO2003026395A3 (fr) Disruptions geniques mo54, compositions et procedes correspondants
WO2002003789A3 (fr) Souris transgéniques contenant des disruptions géniques gpcr ciblées
WO2002040662A3 (fr) Souris transgenique contenant des disruptions geniques ciblees
WO2001067855A3 (fr) Souris transgeniques contenant des interruptions de genes ciblees
WO2002048345A3 (fr) Souris transgeniques presentant des disruptions geniques du recepteur de glutamate (grik5)
WO2002045498A3 (fr) Souris transgenique presentant des disruptions geniques ciblees de proteine canal
WO2002001950A3 (fr) Souris transgeniques contenant des interruptions de genes cibles
WO2002048342A3 (fr) Souris transgeniques presentant des interruptions du gene trp6 au niveau du canal ion calcium
WO2002081658A3 (fr) Souris transgeniques comportant des disruptions geniques sur le canal des ions calcium cacnb4
WO2002003788A3 (fr) Souris transgeniques contenant des disruptions ciblees du gene de la phosphatase
WO2002003793A3 (fr) Souris transgeniques contenant des disruptions genetiques ciblees
WO2002037957A3 (fr) Souris transgeniques contenant des disruptions geniques de la proteine kinase de perk
WO2002079414A8 (fr) Souris transgeniques contenant des ruptures du gene des canaux de chlorure clcn7
WO2002003787A3 (fr) Souris transgéniques contenant des disruptions géniques ciblées
WO2003026403A3 (fr) Disruptions du gene ctsz, compositions et methodes correspondantes
WO2002003791A3 (fr) Souris transgeniques contenant des interruptions de genes
WO2002079433A3 (fr) Souris transgeniques presentant des disruptions du gene tmem3 de la beta-1,3-n-acetylglucosaminyltransferase
WO2002079412A3 (fr) Souris transgenique presentant des disruption geniques dues a la presence d'une enzyme de desubiquitination de type usp3
WO2002048346A3 (fr) Souris transgeniques contenant des disruptions geniques d'une proteine a ancrage membranaire specifique du cerveau
WO2002055687A3 (fr) Souris transgeniques presentant des disruptions geniques cibles
WO2002046391A3 (fr) Souris transgeniques contenant des interruptions de gene nor1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP